ANTI-CD276 ANTIBODIES (B7H3)
US Patent 10,604,582
Filed on 2017-03-16
Filed on 2017-03-16
Anti-CD276 Antibodies (B7H3)
Canada
2961609
Filed on 2015-09-16
2961609
Filed on 2015-09-16
GENETIC MARKER FOR PREDICTING PROGNOSIS IN PATIENTS INFECTED WITH HEPATITIS C VIRUS
US Application 15/453,903
Filed on 2017-03-08
Filed on 2017-03-08
EVALUATION OF MANTLE CELL LYMPHOMA AND METHODS RELATED THERETO
Patent Cooperation Treaty
PCT/US2017/028628
Filed on 2017-04-20
PCT/US2017/028628
Filed on 2017-04-20
A New Class Of Stable Heptamethine Cyanine Fluorophores And Biomedical Applications Thereof
US Patent 10,280,307
Filed on 2017-05-04
Filed on 2017-05-04
METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47
US Patent 11,053,314
Filed on 2017-04-06
Filed on 2017-04-06
Methods To Eliminate Cancer Stem Cells By Targeting CD47
European Patent
15788253.1
Filed on 2015-10-09
15788253.1
Filed on 2015-10-09
Methods To Eliminate Cancer Stem Cells By Targeting CD47
Canada
2964173
Filed on 2015-10-09
2964173
Filed on 2015-10-09
Methods To Eliminate Cancer Stem Cells By Targeting CD47
Australia
2015329696
Filed on 2015-10-09
2015329696
Filed on 2015-10-09
ANTI-MUTATED KRAS T CELL RECEPTORS
US Patent 11,207,394
Filed on 2017-05-23
Filed on 2017-05-23